How severe is CVE-2023-6515?

CVE-2023-6515 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-6515 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (45th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-6515?

CVE-2023-6515 affects Miateknoloji Mia-med. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-6515?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

Does CVE-2023-6515 have an EU (EUVD) identifier?

Yes. CVE-2023-6515 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-58746.

When was CVE-2023-6515 published?

CVE-2023-6515 was published on 2024-02-08 and last updated on 2026-06-17.

CVE-2023-6515

CVE-2023-6515 is a high-severity vulnerability in Miateknoloji Mia-med with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-639.

Key facts

Severity: High (CVSS 3.x base score 8.8)
EPSS exploit prediction: 1% (45th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2023-58746
Weakness: CWE-639
Affected product: Miateknoloji Mia-med
Published: 2024-02-08
Last modified: 2026-06-17

Description

Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. MİA-MED allows Authentication Abuse. This issue affects MİA-MED: before 1.0.7.

Frequently asked questions

What is CVE-2023-6515?: Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. MİA-MED allows Authentication Abuse. This issue affects MİA-MED: before 1.0.7.
How severe is CVE-2023-6515?: CVE-2023-6515 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-6515 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (45th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-6515?: CVE-2023-6515 affects Miateknoloji Mia-med. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-6515?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2023-6515 have an EU (EUVD) identifier?: Yes. CVE-2023-6515 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-58746.
When was CVE-2023-6515 published?: CVE-2023-6515 was published on 2024-02-08 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:miateknoloji:mia-med:*:*:*:*:*:*:*:*

More vulnerabilities in Miateknoloji Mia-med

CVE-2022-3760 — Critical (CVSS 9.8): Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') vulnerability in Mia Technology…
CVE-2023-6519 — High (CVSS 7.5): Exposure of Data Element to Wrong Session vulnerability in Mia Technology Inc. MİA-MED allows Read Sensitive Strings…
CVE-2023-6518 — High (CVSS 7.5): Plaintext Storage of a Password vulnerability in Mia Technology Inc. MİA-MED allows Read Sensitive Strings Within an…
CVE-2023-6517 — High (CVSS 7.5): Exposure of Sensitive Information Due to Incompatible Policies vulnerability in Mia Technology Inc. MİA-MED allows…

All CVEs affecting Miateknoloji Mia-med →

Other CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities

CVE-2025-40805 — Critical (CVSS 10.0): Affected devices do not properly enforce user authentication on specific API endpoints. This could facilitate an…
CVE-2024-45032 — Critical (CVSS 10.0): A vulnerability has been identified in Industrial Edge Management Pro (All versions < V1.9.5), Industrial Edge…
CVE-2026-62283 — Critical (CVSS 9.9): Nezha Monitoring is a self-hostable, lightweight, servers and websites monitoring and O&M tool. Nezha versions 1.14.13…
CVE-2026-73656 — Critical (CVSS 9.9): Trigger.dev is a platform for building and deploying fully managed AI agents and workflows. Prior to 4.5.6, POST…
CVE-2026-48765 — Critical (CVSS 9.9): TypeBot is a chatbot builder tool. Versions prior to 3.17.0 allow a low-privilege read collaborator to extract a…
CVE-2026-67622 — Critical (CVSS 9.9): Flowise through 3.1.4 contains an insecure direct object reference vulnerability in the OpenAI Assistants integration…

Browse all CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities →